Login / Signup

Added Benefit and Risk of an Additional Biopsy or Targeting With Contrast-Enhanced Ultrasound for Patients With Renal Transplants.

J Scott KriegshauserNirvikar DahiyaMaxwell L SmithNan ZhangRaymond L HeilmanMelissa L StantonScott W YoungMaitray D Patel
Published in: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine (2020)
Contrast-enhanced ultrasound targeting was not useful. Major bleeding complications were higher than expected, possibly due to the additional biopsy away from the operator-preferred location. Obtaining a second renal transplant biopsy from a substantially different area than the initial operator-preferred location provided additional clinically useful information in 10% of patients.
Keyphrases